Biovie Inc (BIVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Operating Expenses | 18,066 | 32,180 | 45,081 | 27,253 | 138,054 |
| Operating Income | -18,066 | -32,180 | -45,081 | -27,253 | -138,054 |
| Interest Expense | 333 | 2,894 | 4,300 | 2,163 | 560 |
| Other Income | 857 | 2,953 | -875 | 3,332 | 8,364 |
| Pre-tax Income | -17,542 | -32,121 | -50,256 | -26,085 | -130,249 |
| Net Income Continuous | -17,542 | -32,121 | -50,256 | -26,085 | -130,249 |
| Net Income | $-17,542 | $-32,121 | $-50,256 | $-26,085 | $-130,249 |
| EPS Basic Total Ops | -12.12 | -73.05 | -154.70 | -106.00 | -1,482.00 |
| EPS Basic Continuous Ops | -11.87 | -71.09 | -154.71 | -105.76 | -1,050.14 |
| EPS Diluted Total Ops | -12.12 | -73.05 | -154.70 | -106.00 | -1,482.00 |
| EPS Diluted Continuous Ops | -11.87 | -71.09 | -154.71 | -105.76 | -1,050.14 |
| EPS Diluted Before Non-Recurring Items | -12.12 | -73.00 | -155.00 | -106.00 | -1,482.00 |
| EBITDA(a) | $-17,825 | $-31,842 | $-44,681 | $-26,916 | $-137,825 |